For the week ending Saturday, March 3, 2018, these were the top five most viewed boards on the cafepharma forums:
Daiichi-Sankyo - job cuts were reportedly being announced. The thread “Reorg” included many of these discussions.
Shire - a national sales meeting was happening this week, and many discussions surrounded these issues. A popular thread was simply titled “NSM."
Allergan - a lot has been happening with Allergan lately, including the FDA delaying its decision on Esmya, a uterine fibroid drug, after European regulators announced an investigation into the liver safety of the drug. Additionally, this ongoing thread about the Allergan/Valeant takeover discussion has been revived.
Amgen - here we see discussions about Praluent, the potential for Amgen battling Pfizer for Celgene, and more.
Sanofi - rounding out the top 5, Sanofi apparently also had a POA meeting this week. Here is a thread with some point-by-point critique of the meeting.
